Alignment Healthcare (ALHC) CHRO receives 23,543 restricted stock units in equity grant

Rhea-AI Filing Summary

Wagner Andreas P. reported acquisition or exercise transactions in this Form 4 filing.

Alignment Healthcare, Inc. reported that Chief Human Resources Officer Andreas P. Wagner received an equity grant in the form of restricted stock units. The award covers 23,543 units, each representing one share of common stock. These units vest in roughly equal one-third installments on each of the first three anniversaries of the grant date, contingent on his continued service with the company. Following this grant, Wagner directly holds 172,230 shares of Alignment Healthcare common stock, reflecting both existing ownership and the new award.

Insights

Equity Compensation Analyst

Routine RSU grant to CHRO, signaling ongoing equity-based compensation alignment.

The filing shows Alignment Healthcare granted Chief Human Resources Officer Andreas P. Wagner 23,543 restricted stock units. RSUs are a standard form of long-term incentive, linking executive rewards to future company performance through share ownership.

The award vests in approximately one-third increments on each of the first three anniversaries of the grant date, conditioned on continued service. This structure encourages retention over several years and gradually increases Wagner’s equity exposure. After the grant, his direct holdings total 172,230 shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wagner Andreas P.

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE CA 92868

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Human Resources Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/13/2026		A		23,543(1)	A	$0	172,230	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents 23,543 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Andreas P. Wagner	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Alignment Healthcare (ALHC) report in this Form 4 for Andreas P. Wagner?

The Form 4 shows that Chief Human Resources Officer Andreas P. Wagner received 23,543 restricted stock units. Each RSU represents one share of Alignment Healthcare common stock, granted as equity compensation to align his interests with long-term shareholder value.

How many Alignment Healthcare (ALHC) shares does Andreas P. Wagner hold after this transaction?

After the reported equity grant, Andreas P. Wagner directly holds 172,230 shares of Alignment Healthcare common stock. This total includes his existing holdings plus the 23,543 newly granted restricted stock units reported in the Form 4 filing.

What are the vesting terms of the 23,543 restricted stock units granted by ALHC?

The 23,543 restricted stock units vest in approximately one-third installments on each of the first three anniversaries of the grant date. Vesting is subject to Wagner’s continued service with Alignment Healthcare through each applicable vesting date.

Was the Alignment Healthcare (ALHC) Form 4 transaction a market purchase or sale?

No, the Form 4 reports a grant of restricted stock units, not an open-market purchase or sale. The transaction code is “A,” indicating a grant or award acquisition as part of Wagner’s compensation, with a stated price per share of $0.0000.

Who is the insider involved in the latest Alignment Healthcare (ALHC) Form 4 filing?

The insider is Andreas P. Wagner, who serves as Chief Human Resources Officer of Alignment Healthcare. The filing records his acquisition of 23,543 restricted stock units as part of an equity compensation award tied to continued service with the company.